Navigation Links
GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting
Date:6/23/2009

ATLANTA, June 23 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based biopharmaceutical company developing human vaccines for diseases caused by the HIV-1 (Human Immunodeficiency Virus), and other infectious agents, today announced the results of its Annual Shareholders Meeting, held on June 18, 2009.

During the meeting, shareholders re-elected seven nominees for directors of the company to serve until the 2010 Annual Meeting of Shareholders and until their successors are duly elected or appointed and qualified. They are: Donald Hildebrand, Andrew Kandalepas, Dean Kollintzas, Robert McNally, Harriet Robinson, John Spencer and Peter Tsolinas. Additionally, stockholders ratified the appointment of Porter Keadle Moore LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2009.

Don Hildebrand, company co-founder and Chairman of the Board of Directors, provided opening remarks at the meeting, highlighting significant progress over the past year. A few of the key advances presented included: GeoVax as being the only company currently conducting Phase 2a clinical trials for an AIDS vaccine in the U.S., excellent safety and immune responses being reported in five completed human trials, the advancement of plans to begin human therapeutic [treatment] trials in the U.S., stable corporate financial condition, rising recent stock price, substantial increase in the number of new investors in GeoVax, substantial press coverage and investor interest at the World BIO Conference in Atlanta, invitations to present GeoVax at various investor conferences and several scientific presentations and publications by Dr. Robinson in the U.S. as well as in Europe.

In addition to the business of the annual meeting, Robert McNally, president and chief executive officer, provided an overview of the company's progress, highlighting GeoVax's
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
2. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
3. Excellent Results Received from GeoVaxs Full-Dose HIV/AIDS Vaccine Trial
4. GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update
5. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
6. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
7. Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program
8. GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials
9. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results
10. GeoVax Secures $10 Million Financing Commitment
11. GeoVax Reports Progress on Its AIDS Vaccine Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 MultiCell Technologies, Inc. (OTC ... U.S. provisional patent application concerning composition of matter, biological ... targeted tumor cell death.  This patent ... double stranded RNA molecules (VSRNAs) which interfere with the ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ...
(Date:1/15/2014)... , Jan. 15, 2014  A novel wearable injector slightly larger ... painless for patients to self-inject prescription drugs in the large ... cancer, blood diseases, autoimmune deficiencies, and genetic disorders.  ... to $220B by 2018, according to analysts.   Many of these ...
Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2
... today announced that Jeff Abbey , the ... of its Arcelis™ dendritic cell-based immunotherapy at 3:30 ... Conference in New York. In addition, Charles ... president of research and development, will participate in a panel ...
... 18 URAC, a leading independent health care quality ... (MRM) program the Bronze Award in Health Information/Decision Support ... Empowerment and Protection Awards. The awards honor programs that ... The Oklahoma Health Care Authority (OHCA) and Oklahoma Department ...
Cached Medicine Technology:Argos Therapeutics to Present Overview of its Arcelis™ Dendritic Cell-based Immunotherapy, Participate in Panel Discussion at Inaugural Cancer Immunotherapy Conference 2Health Care Coordination Program Honored With URAC National Best Practices Award 2Health Care Coordination Program Honored With URAC National Best Practices Award 3Health Care Coordination Program Honored With URAC National Best Practices Award 4
(Date:4/20/2014)... A single type of cell in the lining ... invasive bladder cancer, according to researchers at the Stanford ... mice, is the first to pinpoint the normal cell ... It,s also the first to show that most bladder ... one cell, and explains why many human bladder cancers ...
(Date:4/18/2014)... published online in The Gerontologist ... is associated with a decrease in anxiety about death ... control over their lives. In particular, listening to gospel ... death and an increase in sense of control. , ... and men, and individuals of both low- and high-socioeconomic ...
(Date:4/18/2014)... worst memories? How did it make you feel? According ... personal experience, such as how sad you were or ... especially when you can,t stop thinking about it. ... the context of the memories, rather than how you ... alleviate the negative effects of these memories, a new ...
(Date:4/18/2014)... (April 18, 2014) ― A new study in the ... patterns in health-related Google searches reveals a recurring pattern ... , Investigators from San Diego State University, ... Monday Campaigns, analyzed "healthy" Google searches (searches that included ... diet") originating in the U.S. from 2005 to 2012. ...
(Date:4/17/2014)... in benign prostate tissue was associated with high-grade, ... found even in those with low prostate-specific antigen ... Cancer Epidemiology, Biomarkers & Prevention , a ... , An analysis of prostate tissue biopsies collected ... the Prostate Cancer Prevention Trial (PCPT) found that ...
Breaking Medicine News(10 mins):Health News:Stanford scientists identify source of most cases of invasive bladder cancer 2Health News:Stanford scientists identify source of most cases of invasive bladder cancer 3Health News:Stanford scientists identify source of most cases of invasive bladder cancer 4Health News:Stanford scientists identify source of most cases of invasive bladder cancer 5Health News:Religious music brings benefit to seniors' mental health 2Health News:New study suggests a better way to deal with bad memories 2Health News:New study suggests a better way to deal with bad memories 3Health News:New research shows people are thinking about their health early in the week 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3
... Association of California Nurse Leaders Supports Research Efforts ... AMN Healthcare congratulates Tanya Osborne-McKenzie, RN, who was ... the 31st annual Association of California Nurse Leaders ... by ACNL. Osborne-McKenzie is the director of ...
... 26 Digital Power Corporation (NYSE Amex: DPW ... and for the year ended December 31, 2008.Digital Power reported ... 3l, 2008, compared to net income of $235,000 for the ... for the fourth quarter of 2008, compared to operating income ...
... SCIENTIST: A GUIDE TO RESPONSIBLE CONDUCT IN RESEARCH, THIRD ... Academy of Engineering, and Institute of Medicine, offers researchers ... on the ethical conduct of scientific research. ... to help readers consider how to respond in complex ...
... Specialized Leases from Elekta Facilitate Sharing of Financial ... health systems are facing a "perfect storm" as ... layoffs and federal cuts, and investment income dwindles. ... from other medical facilities, but from new entrants ...
... Coast Independent Review Board (IRB), testified today before the Subcommittee ... Committee in the Rayburn House Office Building. Coast IRB ... clandestine sting operation at the request of the Committee. ... Coast had committed any crime. No crime was unearthed ...
... to aid in recognizing, treating rare but real condition ... about the symptoms and outcomes of a relatively rare ... been collected by U.S. researchers into a registry of ... 70 people in the new registry -- nearly all ...
Cached Medicine News:Health News:Tanya Osborne-McKenzie Wins AMN Healthcare ACNL Scholarship 2Health News:Digital Power Reports Financial Results for the Fourth Quarter and the Year Ended December 31, 2008 2Health News:Digital Power Reports Financial Results for the Fourth Quarter and the Year Ended December 31, 2008 3Health News:Digital Power Reports Financial Results for the Fourth Quarter and the Year Ended December 31, 2008 4Health News:New Focus Placed on Alternative Financing as Hospitals Seek Competitive Advantage During Challenging Economic Conditions 2Health News:New Focus Placed on Alternative Financing as Hospitals Seek Competitive Advantage During Challenging Economic Conditions 3Health News:Coast IRB Tells Congressional Committee Sting Operation Was Illegal, Unnecessarily Harmful 2Health News:Registry Created for Broken Heart Syndrome 2
... a electronic medical records software for healthcare ... Medical Office Records does more than just ... to follow the flow of your patient ... encounters to establishing new examination records via ...
... The eCHARMS suite comprises the ... 2000 product line. Currently, there ... signature & enterprise-wide disclosure reporting. ... new HIM management tool. These ...
... Electronic Medical Office (EMO) truly built for ... unique needs of your practice. The ChartLogic™ ... record system (EMR, EHR, and EPR), and ... new level of efficiency and performance. In ...
... serving the needs of orthopaedic practices ... a better orthopaedic practice, an orthopaedic ... EMR software has been intuitively developed ... country resulting in a complete workflow ...
Medicine Products: